Clinical Trial Update: NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial of NovoLog (insulin aspart) in subjects with Type 1 and Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED